GlassScriptPhysician profile
Zachery Barnett
NPI 1306288584
$9,675.33
in general payments reported to CMS, 2019-2025
35 companies · $579 in 2025
The $579 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,267 · 2020: $743 · 2021: $131 · 2022: $858 · 2023: $1,100 · 2024: $996 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,191 · Travel and Lodging: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,191.08 |
| Travel and Lodging | $484.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,861.75 | 2019-2024 | |
| Stryker Corporation | $1,261.09 | 2019-2025 | Variax, Actishield Cf, Actishield |
| Mvp Orthopedics INC | $520.00 | 2019 | |
| Dne LLC | $496.07 | 2022 | |
| Paragon 28, INC. | $432.40 | 2023-2024 | Ankle Fracture, Additive Orthopedics, Portfolio |
| Biotissue Holdings INC. | $273.75 | 2021-2022 | |
| Nevro Corp. | $143.93 | 2023 | Senza |
| Medshape, INC. | $141.18 | 2025 | |
| Globus Medical, INC. | $135.23 | 2025 | Senza |
| Coastal Medical Technologies LLC | $130.41 | 2024 | |
| Orthofix Medical, INC. | $127.80 | 2022-2023 | Physio-Stim |
| Medline Industries LP | $119.59 | 2020 | |
| Treace Medical Concepts, INC. | $111.22 | 2023 | |
| Wright Medical Technology, INC. | $107.96 | 2019-2020 | |
| Bioventus LLC | $80.94 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $80.01 | 2020 | |
| Smith+Nephew, INC. | $78.67 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System |
| Crossroads Extremity Systems, LLC | $74.66 | 2019 | |
| Dynasplint Systems INC. | $74.11 | 2021 | |
| Kerecis Limited | $54.81 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Aroa Biosurgery Incorporated | $45.40 | 2020-2025 | |
| Convatec INC. | $44.54 | 2023-2024 | |
| W. L. Gore & Associates, INC. | $40.14 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Depuy Synthes Sales INC. | $38.87 | 2025 | Crosstie |
| Bsn Medical INC | $33.27 | 2025 | |
| Surgenex LLC | $22.51 | 2025 | Surmatrix, Ardeograft, Surgraft |
| Paratek Pharmaceuticals, INC. | $20.69 | 2024 | Nuzyra |
| Organogenesis INC. | $19.15 | 2023 | Puraply |
| Hydrofera LLC | $18.26 | 2024 | Hydrofera Blue |
| Nabriva Therapeutics, Plc | $17.64 | 2020 | |
| Curonix LLC | $16.69 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zimmer Biomet Holdings, INC. | $15.99 | 2019 | |
| Fidia Pharma USA INC. | $13.57 | 2023 | Hymovis, Triluron |
| Kci USA, INC. | $12.69 | 2020 | |
| Amniox Medical, INC. | $10.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachery Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.